Company Filing History:
Years Active: 2009
Title: Jennifer Helen Moir: Innovator in Pharmaceutical Chemistry
Introduction
Jennifer Helen Moir is a distinguished inventor based in Newhouse, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Jennifer holds a patent for 4-phenyl-pyrimidine-2-carbonitrile derivatives. This invention relates to derivatives characterized by a specific general formula, where each substituent is defined in the specification and claims. The invention also encompasses pharmaceutical compositions that include these derivatives, which are utilized in the treatment of various conditions such as osteoporosis, atherosclerosis, inflammation, immune disorders like rheumatoid arthritis, and chronic pain, including neuropathic pain. She has been granted 1 patent for her innovative work.
Career Highlights
Jennifer is currently associated with N.V. Organon, where she continues to advance her research and development efforts. Her work has been pivotal in creating new therapeutic options for patients suffering from chronic conditions.
Collaborations
Jennifer has collaborated with notable colleagues, including Jiaqiang Cai and Zoran Rankovic, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jennifer Helen Moir's contributions to pharmaceutical chemistry exemplify her commitment to improving healthcare through innovative inventions. Her work not only enhances our understanding of therapeutic compounds but also provides valuable solutions for various medical conditions.